Patents by Inventor Graham Paul Matthews

Graham Paul Matthews has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Spontaneously dispersible N-benzoyl staurosporine compositions
    Patent number: 8722664
    Abstract: Spontaneously dispersible N-benzoyl-staurosporine compositions are disclosed for oral administration having high bioavailability levels and reduced variability of bioavailability levels of N-benzoyl-staurosporine, as well as their preparation and use in medical treatment.
    Type: Grant
    Filed: October 15, 2013
    Date of Patent: May 13, 2014
    Assignee: Novartis AG
    Inventors: Graham Paul Matthews, Barbara Haeberlin
  • Spontaneously Dispersible N-Benzoyl Staurosporine Compositions
    Publication number: 20140056974
    Abstract: Spontaneously dispersible N-benzoyl-staurosporine compositions are discussed for oral administration having high bioavailability levels and reduced variability of bioavailability levels of N-benzoyl-staurosporine, as well as their preparation and use in medical treatment.
    Type: Application
    Filed: October 15, 2013
    Publication date: February 27, 2014
    Applicant: NOVARTIS AG
    Inventors: Graham Paul Matthews, Barbara Haeberlin
  • Spontaneously dispersible N-benzoyl staurosporine compositions
    Patent number: 8575147
    Abstract: Spontaneously dispersible N-benzoyl-staurosporine compositions are discussed for oral administration having high bioavailability levels and reduced variability of bioavailability levels of N-benzoyl-staurosporine, as well as their preparation and use in medical treatment.
    Type: Grant
    Filed: September 21, 2007
    Date of Patent: November 5, 2013
    Assignee: Novartis AG
    Inventors: Graham Paul Matthews, Barbara Haeberlin
  • Spontaneously dispersible N-benzoyl staurosporine compositions
    Publication number: 20020061873
    Abstract: Spontaneously dispersible N-benzoyl-staurosporine compositions are discussed for oral administration having high bioavailability levels and reduced variability of bioavailability levels of N-benzoyl-staurosporine, as well as their preparation and use in medical treatment.
    Type: Application
    Filed: August 15, 2001
    Publication date: May 23, 2002
    Inventors: Graham Paul Matthews, Barbara Haeberlin
  • Pharmaceutical compositions containing a staurosporine
    Patent number: 5736542
    Abstract: An orally administrable pharmaceutical composition comprising a solution or dispersion of a staurosporine active ingredient in a solid saturated polyalkylene glycol glyceride, such as a mixture of esters of C.sub.8 -C.sub.18 saturated fatty acids with glycerol and polyethylene glycol, is disclosed that may be administered in capsules or as a dispersion in an aqueous medium.
    Type: Grant
    Filed: November 22, 1994
    Date of Patent: April 7, 1998
    Assignee: Novartis Corporation
    Inventors: Roy Lindsay Allen Henry, Graham Paul Matthews